Close

Roth Capital Cuts PT on Heat Biologics (HTBX) by ~27% Following HS-410 Phase 2 Data

Go back to Roth Capital Cuts PT on Heat Biologics (HTBX) by ~27% Following HS-410 Phase 2 Data

Form 424B3 HEAT BIOLOGICS, INC.

December 1, 2016 6:09 AM EST

 




 

 

Prospectus Supplement No. 14

 Filed Pursuant to Rule... More

Form 8-K HEAT BIOLOGICS, INC. For: Nov 30

December 1, 2016 6:07 AM EST

 



 

 

UNITED... More